Monensin Enhances Lead Treatment in Rats
Author Information
Author(s): Hamidinia Shawn A., Erdahl Warren L., Chapman Clifford J., Steinbaugh Gregory E., Taylor Richard W., Pfeiffer Douglas R.
Primary Institution: Ohio State University
Hypothesis
Can monensin improve the effectiveness of meso-dimercaptosuccinate in treating lead intoxication in rats?
Conclusion
Monensin significantly enhances the removal of lead from various tissues when used in combination with meso-dimercaptosuccinate.
Supporting Evidence
- Monensin increased lead removal from femur, brain, and heart in rats.
- The combination of monensin and DMSA was more effective than DMSA alone.
- Monensin showed a tendency to enhance lead removal from liver and kidney.
Takeaway
Monensin helps get rid of lead from rats' bodies better when used with another medicine called DMSA.
Methodology
Male Sprague-Dawley rats were divided into groups and treated with lead, monensin, DMSA, or combinations of these, followed by analysis of lead levels in various tissues.
Potential Biases
Potential bias in treatment effects due to the animal model used.
Limitations
The study was conducted on rats, and results may not directly translate to humans.
Participant Demographics
Male Sprague-Dawley rats, initially weighing 245–255 g.
Statistical Information
P-Value
0.08 in kidney, 0.14 in liver
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website